Tecnovax
Tecnovax is an Argentine biopharmaceutical company founded in 2003 that manufactures biological products for animal health, serving veterinary and livestock markets from Victoria, Argentina. It is a privately held, founder-led firm with 101–250 employees.
- Company typePrivate
- Founded2003
- HeadquartersVictoria, Argentina
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Tecnovax does
Tecnovax is an Argentine biopharmaceutical company that manufactures biological products for animal health. Founded in 2003 and headquartered in Victoria, Argentina, the company operates in the veterinary biologics segment, which typically includes vaccines and other immunological products for livestock and companion animals. The firm is privately held and has sustained operations for 21 years, currently maintaining a workforce of 101–250 employees. Leadership is founder-led, with Diego La Torre serving as co-founder and CEO, providing strategic continuity since inception.
The company's product portfolio, technology platform, manufacturing footprint, and regulatory registrations are not disclosed in the available source data. The corporate website (tecnovax.com.ar) was inaccessible beyond a loading/verification page during data collection, and no product catalog, technical specifications, patents, certifications, or partnership disclosures were available. This represents a significant data gap for evaluating Tecnovax's competitive positioning within the regional and global animal health biologics market.
Tecnovax's business model is also not disclosed in the source material. There is no public information on pricing, distribution channels, customer segments, geographic markets served, or revenue mechanics. As a manufacturer of regulated veterinary biologicals, the most plausible go-to-market is B2B distribution through veterinary wholesalers, livestock producers, and government animal health programs, but this is an inference rather than a documented fact. Investors seeking to diligence the company should request primary documentation on revenue, product registrations, and export footprint.
Tecnovax firmographics
Firmographics- Name
- Tecnovax
- Website
- https://tecnovax.com.ar
- Company type
- Private
- Founded year
- 2003
- Headcount range
- 101–250 employees
- Short description
- Tecnovax is an Argentine biopharmaceutical company founded in 2003 that manufactures biological products for animal health, serving veterinary and livestock markets from Victoria, Argentina. It is a privately held, founder-led firm with 101–250 employees.
- Ownership category
- akta.pro rank
Tecnovax industry classification
Industry- Product category
- Veterinary Biologics
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Veterinary Vaccines (Biologics) (HLAMAEAL)
- akta.pro secondary industry
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
Keywords
Where Tecnovax is headquartered
LocationHeadquarters
- HQ city
- Victoria
- HQ country
- Argentina
- HQ region
- Latin America
Markets served
Tecnovax business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D
Tecnovax product offering
Product offeringCore offering
Tecnovax is a biopharmaceutical company that manufactures biological products for animal health. Founded in 2003 and headquartered in Victoria, Argentina, the company develops and produces veterinary biologics aimed at the livestock and animal health sectors.
Differentiator
Problem solved
Functional benefit
Companies that use Tecnovax
Customer profileIdeal customer profiles1 record
Tecnovax technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Tecnovax partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights1 record
Tecnovax competitors and assessment
Company assessmentBroad incumbents
- Zoetis: Global leader in animal health medicines and vaccines. Directly comparable as a veterinary biologics manufacturer serving livestock and companion animal markets, though at vastly larger scale and with a broad portfolio.
- Boehringer Ingelheim Animal Health: Major multinational animal health division with a strong veterinary vaccines portfolio. Comparable to Tecnovax as a biological products manufacturer for animal health, with broader geographic reach and species coverage.
- MSD Animal Health (Merck Animal Health): Global animal health division of Merck with extensive livestock vaccine and biologic offerings. Direct competitor in the veterinary biologics space across multiple species and geographies.
- Elanco Animal Health: Major global animal health company with significant vaccines and therapeutics portfolio. Comparable as a broad-line animal health biologics competitor.
- Virbac: Global animal health company with vaccines, parasiticides, and specialty products. Comparable to Tecnovax in vaccines/biologics manufacturing scope, though with a broader product mix and global distribution.
- Ceva Santé Animale: Multinational animal health company with a meaningful vaccines and biologics portfolio. Comparable as a biological products manufacturer for animal health, with growing emerging market presence.
- Vetoquinol: Global veterinary pharmaceuticals and biological products company. Comparable in manufacturing veterinary medicines, with overlap on livestock and companion animal categories.
- Phibro Animal Health: Animal health and nutrition company with vaccines and pharmaceutical products for livestock. Comparable as a veterinary biologics and pharmaceutical manufacturer, though with broader nutritional product lines.
Direct peers
- Biogénesis Bagó: Argentine veterinary biologics manufacturer focused on livestock vaccines, including foot-and-mouth disease. The most direct regional peer to Tecnovax, operating from the same home market with a similar product category and customer base.
Regional players
- Instituto Rosenbusch: Argentine veterinary biologics manufacturer focused on livestock vaccines. Closely comparable regional peer operating in the same home geography with a similar product profile.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Tecnovax social profiles
Digital presenceTecnovax financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tecnovax leadership team
Management profileNumber of profiles
Profiles1 record
Tecnovax funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tecnovax M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tecnovax
What does Tecnovax do?
Tecnovax is a biopharmaceutical company that manufactures biological products for animal health. Founded in 2003 and headquartered in Victoria, Argentina, the company develops and produces veterinary biologics aimed at the livestock and animal health sectors.
When was Tecnovax founded?
Tecnovax was founded in 2003. It employs 101 to 250 people.
Where is Tecnovax based?
Tecnovax is headquartered in Victoria, Argentina, in the Latin America region.
Who are Tecnovax's main competitors?
Broad incumbents on record are Zoetis, Boehringer Ingelheim Animal Health, MSD Animal Health (Merck Animal Health), Elanco Animal Health, Virbac, Ceva Santé Animale, Vetoquinol and Phibro Animal Health. Biogénesis Bagó is listed as a direct peer. Instituto Rosenbusch is listed as a regional player.
Does Tecnovax have an API?
No public API is recorded for Tecnovax.
What industry is Tecnovax in?
Tecnovax's product category is Veterinary Biologics. Its primary akta.pro industry code is HLAMAEAL, Veterinary Vaccines (Biologics), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 325414 and its SIC code is 2836.